You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Lorlatinib for previously treated ALK-positive advanced non-small-cell lung cancer

  • Technology appraisal guidance
  • Reference number: TA628
  • Published:  13 May 2020
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Resource impact
  2. Guidance into practice

Tools and resources

Tools to help you put the guidance into practice.

Resource impact

  • Resource impact template (Excel 1.64 MB)

    Published:
    13 May 2020
  • Resource impact report (PDF 255 KB)

    Published:
    13 May 2020

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top